{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:40:36Z","timestamp":1790836836222,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1124\/jpet.111.188078","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T01:03:58Z","timestamp":1323306238000},"page":"629-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems"],"prefix":"10.1016","volume":"340","author":[{"given":"Vedrana","family":"Reichenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Fern\u00e1ndez-Varo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Melgar-Lesmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morales-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.188078_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.24395","article-title":"The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.111.188078_bib2","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.111.188078_bib3","series-title":"The Liver and the Kidney","first-page":"379","article-title":"Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats","author":"Cl\u00e0ria","year":"1999"},{"key":"10.1124\/jpet.111.188078_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1096\/fj.05-5243fje","article-title":"TNF-\u03b1 up-regulates apelin expression in human and mouse adipose tissue","volume":"20","author":"Daviaud","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.188078_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005844","article-title":"Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis","volume":"4","author":"Deveaux","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/jpet.111.188078_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.111.188078_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.111.188078_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"Gressner","year":"2007","journal-title":"Comp Hepatol"},{"key":"10.1124\/jpet.111.188078_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2007.11.039","article-title":"Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C","volume":"134","author":"H\u00e9zode","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.111.188078_bib10","article-title":"A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia\/reperfusion injury","author":"Horv\u00e1th","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188078_bib11","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.188078_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.111.188078_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.111.188078_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.1840050517","article-title":"Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method","volume":"5","author":"Jimenez","year":"1985","journal-title":"Hepatology"},{"key":"10.1124\/jpet.111.188078_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.111.188078_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","article-title":"Modification of the terminal residue of apelin-13 antagonizes its hypotensive action","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.111.188078_bib17","first-page":"430","article-title":"[Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors]","volume":"16","author":"Liu","year":"2008","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1124\/jpet.111.188078_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","article-title":"CB2 cannabinoid receptor-mediated peripheral antinociception","volume":"93","author":"Malan","year":"2001","journal-title":"Pain"},{"key":"10.1124\/jpet.111.188078_bib19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0168-8278(99)80327-4","article-title":"Hepatic stellate cells and the regulation of liver inflammation","volume":"31","author":"Marra","year":"1999","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.111.188078_bib20","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1096\/fj.04-1930fje","article-title":"Apelin (65\u201377) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells","volume":"18","author":"Masri","year":"2004","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.188078_bib21","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1210\/en.2010-0754","article-title":"Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells","volume":"151","author":"Melgar-Lesmes","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.111.188078_bib22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2010.234690","article-title":"Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes","volume":"60","author":"Melgar-Lesmes","year":"2011","journal-title":"Gut"},{"key":"10.1124\/jpet.111.188078_bib23","series-title":"Portal Hypertension: Pathobiology, Evaluation, and Treatment","first-page":"99","article-title":"Neovascularization, angiogenesis, and vascular remodelling in portal hypertension","author":"Morales-Ruiz","year":"2005"},{"key":"10.1124\/jpet.111.188078_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.131896","article-title":"Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats","volume":"324","author":"Mu\u00f1oz-Luque","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188078_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.111.188078_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI114363","article-title":"Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells","volume":"84","author":"Pinzani","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.111.188078_bib27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.22467","article-title":"The hepatic apelin system: a new therapeutic target for liver disease","volume":"48","author":"Principe","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/jpet.111.188078_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gastrohep.2009.06.010","article-title":"Endogenous cannabinoids in liver disease: many darts for a single target","volume":"33","author":"Reichenbach","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1124\/jpet.111.188078_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.bjp.0706375","article-title":"Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention","volume":"146","author":"Ros","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188078_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","article-title":"Endocannabinoids in liver disease","volume":"53","author":"Tam","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/jpet.111.188078_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/jpet.111.188078_bib32","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/jpet.111.188078_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjp.0706838","article-title":"In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?","volume":"149","author":"Yao","year":"2006","journal-title":"Br J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.188078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:58:32Z","timestamp":1743188312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022356524467621"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.188078","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.188078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}